Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
Efficacy of Ciclesonide and of a Fixed Combination With Fluticasone Propionate and Salmeterol Versus Placebo on Long-term Asthma Control
1 other identifier
interventional
630
7 countries
111
Brief Summary
The aim of the study is to compare the efficacy of ciclesonide versus fixed combination of fluticasone propionate/salmeterol versus placebo, on long-term asthma control in patients with mild persistent asthma. The study duration consists of a baseline period (2 weeks) and a treatment period (12 months). The study will provide further data on safety and tolerability of ciclesonide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 asthma
Started Sep 2003
Typical duration for phase_3 asthma
111 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedNovember 30, 2016
October 1, 2016
2.1 years
September 12, 2005
November 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
time until the first severe asthma exacerbation occurs
number of poorly controlled asthma days.
Secondary Outcomes (14)
percentage of days with asthma control
percentage of days with asthma symptoms
percentage of nocturnal awakenings due to asthma
asthma symptom score
number of inhalations of rescue medication
- +9 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of mild persistent asthma
- Pre-treatment with SABAs only
- FEV1 ≥80% predicted
- Good health with the exception of asthma
You may not qualify if:
- Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids
- COPD (chronic bronchitis or emphysema) and/or other relevant lung diseases causing alternating impairment in pulmonary function
- Pregnancy
- Intention to become pregnant during the course of the study
- Breast feeding
- Lack of safe contraception
- Current smokers ≥10 pack-years and ex-smokers with ≥10 pack-years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (111)
Altana Pharma/Nycomed
Adelaide South Australia, 5000, Australia
Altana Pharma/Nycomed
Auchenflower, QLD 4066, Australia
Altana Pharma/Nycomed
Bracken Ridge, QLD 4017, Australia
Altana Pharma/Nycomed
Burwood, NSW 2134, Australia
Altana Pharma/Nycomed
Camperdown, NSW 2050, Australia
Altana Pharma/Nycomed
Carina Heights, QLD 4152, Australia
Altana Pharma/Nycomed
Clayton, VIC 3168, Australia
Altana Pharma/Nycomed
Concord, 2139, Australia
Altana Pharma/Nycomed
Geelong, VIC 3220, Australia
Altana Pharma/Nycomed
Inala, QLD 4077, Australia
Altana Pharma/Nycomed
Kippa-Ring, QLD 4021, Australia
Altana Pharma/Nycomed
Nedlands, WA 6009, Australia
Altana Pharma/Nycomed
Rosebud, VIC 3939, Australia
Altana Pharma/Nycomed
South Brisbane, QLD 4101, Australia
Altana Pharma/Nycomed
Toorak Gardens, SA 5056, Australia
Altana Pharma/Nycomed
Wayville, SA 5034, Australia
Altana Pharma/Nycomed
Beaconsfield, QC, H9W2X3, Canada
Altana Pharma/Nycomed
Coquitlam, V3K 3P4, Canada
Altana Pharma/Nycomed
Coquitlam, BC, V3K 3V9, Canada
Altana Pharma/Nycomed
Corner Brook, NFLD, Canada
Altana Pharma/Nycomed
Cowansville, J2K2X9, Canada
Altana Pharma/Nycomed
Kingston, Ontario, K7L 2V6, Canada
Altana Pharma/Nycomed
Langley BC, V3A 4H9, Canada
Altana Pharma/Nycomed
Laval, H7V3Y7, Canada
Altana Pharma/Nycomed
Les Saules, QC, G1P 1J6, Canada
Altana Pharma/Nycomed
Longueuil, PQ, J4N 1E1, Canada
Altana Pharma/Nycomed
Montreal, H4J1C5, Canada
Altana Pharma/Nycomed
Montreal, PQ, H3H 1V4, Canada
Altana Pharma/Nycomed
North Bay, P1B2H3, Canada
Altana Pharma/Nycomed
North York, M3H 3S3, Canada
Altana Pharma/Nycomed
Ottawa, K1Y 4G2, Canada
Altana Pharma/Nycomed
Penticton, BC, V2A 5C8, Canada
Altana Pharma/Nycomed
Québec, G8T 7A1, Canada
Altana Pharma/Nycomed
Saint John, E2K2T8, Canada
Altana Pharma/Nycomed
Sainte-Foy, Quebec, G1V4G5, Canada
Altana Pharma/Nycomed
Saskatoon, SK, S7K 3H3, Canada
Altana Pharma/Nycomed
St. John's, A1A 3R5, Canada
Altana Pharma/Nycomed
St. John's, A1E 2C2, Canada
Altana Pharma/Nycomed
Ste-Foy PQ, G1V 4M6, Canada
Altana Pharma/Nycomed
Toronto, M4N3N5, Canada
Altana Pharma/Nycomed
Toronto, M4P1P2, Canada
Altana Pharma/Nycomed
Toronto, M9W 4L6, Canada
Altana Pharma/Nycomed
Toronto on, M5S 2A5, Canada
Altana Pharma/Nycomed
Beroun, 266 01, Czechia
Altana Pharma/Nycomed
Cvikov, 471 54, Czechia
Altana Pharma/Nycomed
Česká Lípa, 470 01, Czechia
Altana Pharma/Nycomed
Havlickuv, 580 01, Czechia
Altana Pharma/Nycomed
Jihlava, 58601, Czechia
Altana Pharma/Nycomed
Jindřichův Hradec, 377 01, Czechia
Altana Pharma/Nycomed
Karlovy Vary, 360 00, Czechia
Altana Pharma/Nycomed
Kladno, 272 01, Czechia
Altana Pharma/Nycomed
Kutná Hora, 28401, Czechia
Altana Pharma/Nycomed
Ostrava-Marián.Hory, 70030, Czechia
Altana Pharma/Nycomed
Prague, 100 00, Czechia
Altana Pharma/Nycomed
Prague, 128 00, Czechia
Altana Pharma/Nycomed
Prague, 14046, Czechia
Altana Pharma/Nycomed
Prague, 181 00, Czechia
Altana Pharma/Nycomed
Prague, 190 61, Czechia
Altana Pharma/Nycomed
Pribram VI, 261 05, Czechia
Altana Pharma/Nycomed
Príbram VIII, 261 01, Czechia
Altana Pharma/Nycomed
Rokycany, 337 01, Czechia
Altana Pharma/Nycomed
Strakonice, 38601, Czechia
Altana Pharma/Nycomed
Trutnov, 54101, Czechia
Altana Pharma/Nycomed
Ústí nad Labem, 401 13, Czechia
Altana Pharma/Nycomed
Budapest, 1046, Hungary
Altana Pharma/Nycomed
Budapest, 1134, Hungary
Altana Pharma/Nycomed
Budapest, 1529, Hungary
Altana Pharma/Nycomed
Budapest XI, 1117, Hungary
Altana Pharma/Nycomed
Budapet, 1529, Hungary
Altana Pharma/Nycomed
Kecskemét, 6000, Hungary
Altana Pharma/Nycomed
Nyíregyháza, 4400, Hungary
Altana Pharma/Nycomed
Szarvas, 5540, Hungary
Altana Pharma/Nycomed
Tatabánya, 2800, Hungary
Altana Pharma/Nycomed
Bydgoszcz, 85-091, Poland
Altana Pharma/Nycomed
Bydgoszcz, 85-681, Poland
Altana Pharma/Nycomed
Lodz, 91-520, Poland
Altana Pharma/Nycomed
Lódz', 90-153, Poland
Altana Pharma/Nycomed
Rzeszów, 35-068, Poland
Altana Pharma/Nycomed
Rzeszów, 35-302, Poland
Altana Pharma/Nycomed
Warsaw, 01-138, Poland
Altana Pharma/Nycomed
Wroclaw, 50-417, Poland
Altana Pharma/Nycomed
Wroclaw, 53-674, Poland
Altana Pharma/Nycomed
Arcadia, Pretoria, 132, South Africa
Altana Pharma/Nycomed
Bellville, Cape Town, 7530, South Africa
Altana Pharma/Nycomed
Berea, Durban, 4000, South Africa
Altana Pharma/Nycomed
Bloemfontein, 9300, South Africa
Altana Pharma/Nycomed
Bloemfontein, 9301, South Africa
Altana Pharma/Nycomed
Cape Town, 7764, South Africa
Altana Pharma/Nycomed
Centurion, Pretoria, 157, South Africa
Altana Pharma/Nycomed
Daveyton, 1520, South Africa
Altana Pharma/Nycomed
Durban, Amanzimtoti, 4126, South Africa
Altana Pharma/Nycomed
George, 6539, South Africa
Altana Pharma/Nycomed
Midrand, 1685, South Africa
Altana Pharma/Nycomed
Mowbray, Cape Town, 7925, South Africa
Altana Pharma/Nycomed
Paarl, 7646, South Africa
Altana Pharma/Nycomed
Panorama / RSA-Cape Town, 7500, South Africa
Altana Pharma/Nycomed
Pretoria, 186, South Africa
Altana Pharma/Nycomed
Alcorcón (Madrid), 28922, Spain
Altana Pharma/Nycomed
Alicante, 3001, Spain
Altana Pharma/Nycomed
Alicante, 3540, Spain
Altana Pharma/Nycomed
Barcelona, 8222, Spain
Altana Pharma/Nycomed
Campdevanol (Girona), 17530, Spain
Altana Pharma/Nycomed
Elda (Alicante), 3600, Spain
Altana Pharma/Nycomed
Guadalajara, 19002, Spain
Altana Pharma/Nycomed
Leganes (Madrid), 28914, Spain
Altana Pharma/Nycomed
Palma de Mallorca, 7014, Spain
Altana Pharma/Nycomed
Peralada (Girona), 17491, Spain
Altana Pharma/Nycomed
Petrer (Alicante), 3610, Spain
Altana Pharma/Nycomed
San Vicente Del Raspeig (Alicante), 3187, Spain
Altana Pharma/Nycomed
Santiago de Compostela, 15706, Spain
Altana Pharma/Nycomed
Valencia, 46017, Spain
Related Publications (1)
Postma DS, O'Byrne PM, Pedersen S. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. Chest. 2011 Feb;139(2):311-318. doi: 10.1378/chest.09-1735. Epub 2010 Nov 18.
PMID: 21088114DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
AstraZeneca AstraZeneca
AstraZeneca
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 14, 2005
Study Start
September 1, 2003
Primary Completion
October 1, 2005
Study Completion
October 1, 2005
Last Updated
November 30, 2016
Record last verified: 2016-10